Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 3,600 | 0 | 0 | 0 |
| Gross Profit | N/A | 3,600 | N/A | N/A | N/A |
| Operating Expenses | 33,065 | 33,839 | 33,940 | 41,037 | 44,025 |
| Operating Income | -33,065 | -30,239 | -33,940 | -41,037 | -44,025 |
| Other Income | 1,576 | 1,200 | 1,223 | 923 | 283 |
| Pre-tax Income | -31,489 | -29,039 | -32,717 | -40,114 | -43,742 |
| Income Tax | 21 | 17 | 19 | 17 | 19 |
| Net Income Continuous | -31,510 | -29,056 | -32,736 | -40,131 | -43,761 |
| Net Income | $-31,510 | $-29,056 | $-32,736 | $-40,131 | $-43,761 |
| EPS Basic Total Ops | -3.13 | -2.90 | -3.40 | -4.00 | -4.40 |
| EPS Basic Continuous Ops | -3.13 | -2.90 | -3.27 | -4.03 | -4.42 |
| EPS Diluted Total Ops | -3.13 | -2.90 | -3.40 | -4.00 | -4.40 |
| EPS Diluted Continuous Ops | -3.13 | -2.90 | -3.27 | -4.03 | -4.42 |
| EPS Diluted Before Non-Recurring Items | -3.10 | -2.90 | -3.30 | N/A | N/A |
| EBITDA(a) | $-32,246 | $-29,607 | $-32,831 | $-39,784 | $-42,376 |